– Following the announcement of the multidisciplinary research program last year, the selection process for funded projects has been completed
– Six projects involving eleven scientific institutions from six European countries are supported by Merck and Intel
– The focus is on the application of Artif…

– Acquisition will advance Merck’s integrated offering for viral vector manufacturing
– Complements existing portfolio for development and production of novel modalities such as cell and gene therapies
– Novel modalities are a key growth area for Merck’s Life Science business sector

Merck, a leading science…

– German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony
– Research center to accelerate biopharmaceutical product development
– Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025

Merck, a leading science and technology compan…

– Site to supply products to customers for development and production of biologics
– New Bioprocessing Production Center in Daejeon strengthens footprint of Merck in fast-growing Asia-Pacific region
– Investment to create up to 300 additional jobs

Merck invests more than € 300 million into a new Bioproc…

– Further develops its biosafety testing laboratories to meet local demand
– New labs complete 2nd phase of company’s € 29 million Biologics Testing Center opened in 2022
– Enhances BioReliance® testing services portfolio in the Chinese market

Merck, a leading science and technology company, has completed th…

– Collaborative research program to harness and augment state-of-the-art artificial intelligence
– Aiming for breakthroughs in more sustainable semiconductor processes and manufacturing technologies

Merck, a leading science and technology company, and Intel Corporation, one of the world’s largest semi…

– Increases manufacturing capacity for the Mobius® single-use portfolio
– Creates more than 800 jobs by the end of 2028
– Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025
– Supports Life Science’s strategy to invest in produ…

– Collaboration will help enable real-time release and Bioprocessing 4.0
– Merck to offer integrated capabilities for downstream process monitoring and control
– Online Process Analytical Technologies a critical tool towards implementing continuous manufacturing to realize Bioprocessing 4.0

Merck, a leadi…

– Company to invest in two major Life Science projects over five years
– Significantly increases membrane manufacturing capacities and enables construction of new filtration manufacturing facility
– Supports Merck’s strategy to invest in products and technologies across its portfolio that are key to…

– New operating model to accelerate profitable growth strategy
– Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
– Science and Lab Solutions business unit to combine Research Solutions and Applied Solutions
– Christos Ross, Head of Integrated…